Please login to the form below

Not currently logged in
Email:
Password:

New accounts: October

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period July to September 2005 inclusive

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period July to September 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com

Allergan

Botox

Neurology

Jango

Bristol-Myers Squibb

New product

Ultrasound contrast agents

PAN Advertising

Cardinal Health

Physeptone

Addiction

Lowe Azure

Galderma

New product

Dermatology

Life

Link Pharmaceuticals

Gliadel implant

Oncology

Addjuice

Napp Pharmaceuticals

New product

Analgesia

Langland

Pfizer

New product

Ophthalmology

The Medical Multimedia Company

Roche

New product

Oncology

MJL

Royal Free Hospital

Fundraising

HIV/HCV/HBV

MJL

Royal Numico (global)

Cubitan

Woundcare nutrition

central

Royal Numico (global)

Cubison

Woundcare nutrition

central

Strakan

Rectogesic

Anal fissures

VB Communications

Wyeth

Efexor XL

Psychiatry

PAN Advertising

2nd September 2008

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics